Syngene International Q3 PAT falls 44 pc to Rs 73 cr

SUMMARY

AI Generated Content
  • Syngene profit dips 44% to Rs 73 crore Q3.
  • Revenue declines to Rs 917 crore.
  • Syngene extends Bristol Myers Squibb deal to 2035.
AD
AD